Seeing that the workers had quieted down and most of them were thinking, Chen Xia continued to cheer them on:
"So...don't forget that my grandfather and aunt are also from Yuezhou. When fellow countrymen meet, they will...ah, of course they won't cheat on their fellow countrymen."
At this time, someone below shouted, "Section Chief Chen, how can you be sure that Hong Kong people are willing to pay high wages?"
"I can guarantee high wages, and I use my reputation as a guarantee. As long as the workers stay in the new company and work diligently, their basic salary will not be less than 50 yuan per month. In addition, the new company will set up bonuses. Yes, there are bonuses in addition to wages, but this bonus is based on more work, more pay. In the future, it will no longer be a communal meal. It will be the same regardless of how much you work.
In addition, let me be frank. I know that some people in the pharmaceutical factory are dishonest, don't want to work, and want to cause trouble all day long. Our agreement with the region specifically states that the new company has the right to fire these employees.
So while your personnel relationships are still fresh, those with connections should use their connections to transfer to other factories. Otherwise, if you don't perform well, you won't be able to get away with just a few words of criticism."
As soon as these words were spoken, everyone started to make their own calculations.
Most people have been persuaded that, yes, if they are so poor, what else do they have to lose? Can a working-class identity really make a living?
Although the Yuezhou Textile Factory is also in a semi-shutdown state, their workers have skills and can go to township enterprises to earn extra money.
But there are only a few pharmaceutical factories in Yuezhou, and everyone's life is similar, so even if they have pharmaceutical technology, they have no place to make extra money. This industry is really too special.
Now that they have the opportunity to work for a foreign-funded enterprise, what else can they do? They just work hard. As long as their income can be as high as that of Qingfeng Pharmaceutical Factory, they will be completely satisfied.
The situation where workers strongly resisted enterprise restructuring like in the north did not occur. It has to be said that the people of Yuezhou have a strong ability to adapt, and Yuezhou lawyers will never go to extremes in doing things.
In this way, the Xiangjiang team took over the Yuezhou Pharmaceutical Factory as quickly as possible.
The region was very powerful this time, and all retired workers were stripped of their benefits, including those who wanted to retire early.
Another part of the employees chose to transfer to other positions, including the vast majority of factory leaders and some workers with connections. They all used their connections to go to other state-owned factories to continue their lives.
Chen Xia was secretly happy for a long time that this group of people voluntarily relocated, otherwise he would have to try every possible way to drive these old men away.
The soldiers are all incompetent, and the generals are all incompetent. The current situation of Yuezhou Pharmaceutical Factory is directly related to this group of incompetent factory leaders and some troublemakers.
The remaining workers have started formal pre-job training with Ye Xin, the head of the Human Resources Department of Pumpkin Vine. These workers have a certain level of education, and most of them have rich experience in pharmaceutical manufacturing. They can all take up their posts quickly after training.
As for Ye Shirong, he started to carry out comprehensive renovation of the factory. The construction requirements of the pharmaceutical production workshop have a strict set of standards.
Chen Xia’s requirement was to modernize it as much as possible and no longer be as small-scale as the Qingfeng Pharmaceutical Factory, so the vigorous infrastructure construction began.
Everything is moving in the right direction.
Let professionals handle professional matters. Chen Xia was a doctor in his previous life, not an entrepreneur, let alone a pharmaceutical researcher, so apart from making unexpected arrangements, he is not of much use otherwise.
As a professional doctor, he has important things to do.
The Lancet magazine has published two serial papers in the past two months.
The fourth paper, "Clinical Treatment Research on Helicobacter pylori Infection," was first authored by Chen Chun, second author by Xuan Yongda, and corresponding author by Chen Xia.
The fifth paper, "Research Progress and Clinical Application Evaluation of Proton Pump Inhibitors", was first authored by Zheng Haisheng, second author by Wang Yiqun, and the corresponding author was still Chen Xia.
These two papers are actually sister papers. The main content is that they clearly state that quadruple therapy can cure Helicobacter pylori, and the cure rate reaches an astonishing 90%.
The new pharmaceutical concept of proton pump inhibitors was officially introduced, and it was emphasized that the first-generation product "omeprazole" had already been released.
The Lancet published five papers in less than a year. This unconventional approach naturally attracted strong attention from the international mainstream medical community.
Chen Xia’s “doubling the dollar” effect was fully utilized.
The public relations fees for the five papers alone amounted to $1 million. You should know that at that time, the average European and American worker only earned $10,000 a year. Money cannot make the devil work, and this is the same in every country.
What? Bottom line? Aren't bottom lines meant to be broken?
If the first three papers are limited to academic research, the content of the fourth and fifth papers is directly clinical treatment, which is very meaningful.
Every year, there are many papers proposing some medical research directions, but very few of them propose treatment plans, or even some that are untreatable, so the attention they attract will be much smaller.
For example, you discovered gastric cancer and then studied its causative factors, pathophysiology, etc. in great detail. When everyone saw it, they would think: Oh, so this is how gastric cancer comes about. They would understand, but they would not be shocked in their hearts.
But suddenly one day, someone announced that he had developed a drug or surgery that could cure stomach cancer. That would definitely be big news that would shock the world.
Doctors all know that the most common diseases in gastroenterology, such as gastritis, peptic ulcer, reflux esophagitis, etc. are all caused by excessive secretion of gastric acid. Even the occurrence of gastric cancer may have a certain relationship with gastric acid.
But even though we know it, there is no way to cure it completely. We can only watch the patient's condition continue to deteriorate.
Now someone suddenly tells you that they have invented a treatment plan that can not only inhibit excessive secretion of gastric acid, but also kill a pathogenic bacteria in the gastric acid. Wouldn’t this shock everyone?
The concepts, treatment plans, and new drugs proposed are all international firsts.
Now, these five papers by Chen Chun and Zheng Haisheng cover a complete journey from discovery to pathogenicity and then to how to treat it. They have naturally attracted great attention from the international medical community.
Although everyone was still skeptical, or rather, more skeptical than credible, the authority of The Lancet forced them to believe it, and many people in the mainstream medical community began to want to conduct an on-site inspection.
Some large international pharmaceutical companies have also begun to get excited. If it is true as the paper says that there is a way to cure gastritis, peptic ulcer, esophageal reflux disease, etc., then this will be a huge business opportunity.
In the early 1980s, the market for drugs to treat stomach problems alone was worth tens of billions of dollars. If a cure could be achieved, the market would be worth hundreds of billions of dollars, which was very exciting.
Of course, everything needs to be verified first, but when everyone thinks that the inventor is from the poor and closed China, they feel a toothache.
Continue read on readnovelmtl.com
